pSivida Corp. (NASDAQ:PSDV)’s share price was down 3.7% during mid-day trading on Monday . The company traded as low as $3.31 and last traded at $3.36, with a volume of 62,482 shares traded. The stock had previously closed at $3.49.

Separately, FBR & Co reaffirmed a “buy” rating and issued a $7.00 target price (up previously from $6.00) on shares of pSivida Corp. in a report on Thursday, May 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $7.00.

The company’s market capitalization is $114.82 million. The firm’s 50 day moving average is $3.21 and its 200 day moving average is $3.09.

pSivida Corp. (NASDAQ:PSDV) last issued its quarterly earnings data on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.05. Equities analysts expect that pSivida Corp. will post ($0.62) EPS for the current year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).